Skip to main
ACAM

Acamar Partners Acquisition Corp (ACAM)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ACAM Stock

About Acamar Partners Acquisition Corp (ACAM)

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.
Market cap
Today's volume
Revenue (TTM)
Avg. daily volume
EBITDA (TTM)
Open
Price / earnings ratio
Today's range
Debt / equity
52 week range
5 year debt / equity
Beta (LTM)
Interest coverage
Dividend & yield— (—)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

How to buy ACAM stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ACAM stock

    Navigate to the Explore page. Then, type ACAM into the search bar. When you see ACAM stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ACAM stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

Acamar Partners Acquisition Corp Stock Earnings

The value each ACAM share was expected to gain vs. the value that each ACAM share actually gained.

ACAM (ACAM) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, ACAM's earnings per share (EPS) was $0. ACAM is expected to release next earnings on , with an earnings per share (EPS) estimate of $0.

Buy ACAM Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.